Rechercher | Socid Friendly

Subhayan Mayra Ajout d’un nouvel article Health
2026-04-15 11:48:15

Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...

0 Commentaires 0 Parts 2077 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajout d’un nouvel article Autre
2026-04-18 10:04:55

Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...

0 Commentaires 0 Parts 1526 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajout d’un nouvel article Autre
2026-04-20 11:20:27

Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...

0 Commentaires 0 Parts 1610 Vue

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajout d’un nouvel article Autre
2026-04-22 10:36:46

TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034
According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...

0 Commentaires 0 Parts 1383 Vue

Connectez-vous pour aimer, partager et commenter!